IQV IQVIA
Permanent stock page ↗Health Care · S&P 500
Next earnings: not announced yet
What 23 analyst firms say about IQVIA: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
21 rated views · 24 analyst/firm records · 23 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8062
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8069
Recent analyst activity · last 90 days
Our tracked history has 25 reports on IQV from 18 analyst firms in the last 90 days (23 firms in the past year).
Comparing each firm's latest target with its previous one: 12 raised their price target, 1 lowered it, 3 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Jefferies raised its target from $290.00 (set 29 Jul 2026) to $319.00 on 30 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Buy | 6 Jul 2026 | — |
| Baird | Eric Coldwell | Buy | 27 Oct 2026 | 328.00 USD |
| Barclays | Luke Sergott | Buy | 7 Oct 2026 | 300.00 USD |
| BMO Capital Markets | Sean Dodge | ConflictConflicting reports · excluded | 19 Oct 2026 | 305.00 USD |
| BTIG | David M Larsen | Hold | 2 Apr 2026 | — |
| Citigroup | Patrick Donnelly | Hold | 6 Feb 2026 | 200.00 USD |
| Deutsche Bank | Unnamed analyst | — | 15 Oct 2026 | 179.00 USD |
| Evercore ISI | Elizabeth Anderson | Buy | 6 Oct 2026 | Conflicting reports · excluded |
| HSBC | Morten Herholdt | Buy | 3 Jun 2026 | 300.00 USD |
| HSBC | Sidharth Sahoo | Buy | 1 Sep 2026 | 300.00 USD |
| Jefferies | David H Windley | Buy | 30 Oct 2026 | 319.00 USD |
| JPMorgan | Casey Woodring | Buy | 28 Oct 2026 | 325.00 USD |
| Leerink Partners | Michael Cherny | Buy | 15 Jul 2026 | 310.00 USD |
| Mizuho | Ann Hynes | Buy | 7 Oct 2026 | 300.00 USD |
| Morgan Stanley | Kallum Titchmarsh | Hold | 17 Sep 2026 | 270.00 USD |
| RBC Capital Markets | Ryan Halsted | Buy | 29 Sep 2026 | 319.00 USD |
| Redburn | Jamie Clark | Buy | 28 Oct 2026 | 299.00 USD |
| Stifel | Shlomo Rosenbaum | Buy | 14 Oct 2026 | 303.00 USD |
| TD Cowen | Charles Rhyee | Buy | 29 Oct 2026 | 307.00 USD |
| Truist | Jailendra Singh | Buy | 28 Oct 2026 | 346.00 USD |
| UBS | Kevin Caliendo | Buy | 30 Sep 2026 | 345.00 USD |
| Weiss Ratings | Unnamed analyst | — | 28 Oct 2026 | — |
| William Blair | Jared Haase | Buy | 28 Jul 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 20 May 2026 | 273.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:57 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.